Financial Strategies Group Inc. boosted its stake in shares of Select Medical Holdings Co. (NYSE:SEM – Free Report) by 37.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 14,738 shares of the health services provider’s stock after purchasing an additional 4,029 shares during the quarter. Financial Strategies Group Inc.’s holdings in Select Medical were worth $269,000 as of its most recent SEC filing.
Several other large investors also recently bought and sold shares of SEM. Quarry LP purchased a new stake in Select Medical during the 3rd quarter worth about $30,000. GAMMA Investing LLC raised its position in shares of Select Medical by 16.6% during the 3rd quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider’s stock worth $81,000 after acquiring an additional 330 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in shares of Select Medical during the 3rd quarter worth about $81,000. Mount Yale Investment Advisors LLC acquired a new stake in shares of Select Medical during the 3rd quarter worth about $193,000. Finally, Virtu Financial LLC acquired a new stake in shares of Select Medical during the 3rd quarter worth about $210,000. Hedge funds and other institutional investors own 89.48% of the company’s stock.
Analysts Set New Price Targets
SEM has been the subject of several research analyst reports. StockNews.com upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a report on Monday, January 27th. Royal Bank of Canada upped their target price on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Benchmark cut shares of Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. Finally, UBS Group decreased their price target on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a research note on Friday, January 3rd. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $39.50.
Insider Activity
In other news, Director Marilyn B. Tavenner sold 32,000 shares of the stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total value of $674,880.00. Following the completion of the transaction, the director now owns 22,000 shares in the company, valued at $463,980. This trade represents a 59.26 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the transaction, the vice president now owns 30,356 shares of the company’s stock, valued at $605,602.20. This represents a 14.12 % decrease in their position. The disclosure for this sale can be found here. Insiders own 17.50% of the company’s stock.
Select Medical Stock Down 0.9 %
SEM stock opened at $19.66 on Monday. Select Medical Holdings Co. has a one year low of $18.02 and a one year high of $40.98. The stock has a market capitalization of $2.55 billion, a PE ratio of 9.19, a price-to-earnings-growth ratio of 0.66 and a beta of 1.45. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. The company has a fifty day moving average of $19.83 and a 200-day moving average of $29.83.
Select Medical (NYSE:SEM – Get Free Report) last released its earnings results on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, topping the consensus estimate of $0.36 by $0.07. The company had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The business’s revenue was up 5.7% on a year-over-year basis. During the same quarter last year, the business earned $0.46 EPS. As a group, analysts expect that Select Medical Holdings Co. will post 1.97 EPS for the current year.
About Select Medical
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
See Also
- Five stocks we like better than Select Medical
- 3 Dividend Kings To Consider
- 3X-Leveraged ETFs: Amplify Returns With These 3 Top Picks
- Stock Market Upgrades: What Are They?
- 3 Underrated Robotics Stocks Poised for Major Growth
- Stock Market Sectors: What Are They and How Many Are There?
- Reshoring Riches: Investing in Made in America 2.0
Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Co. (NYSE:SEM – Free Report).
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.